Tissue Engineering of heart valves—Immunologic and inflammatory challenges of the allograft scaffold

Cannegieter, 1994, Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses, Circulation, 89, 635, 10.1161/01.CIR.89.2.635 Cannegieter, 1995, Optimal oral anticoagulant therapy in patients with mechanical heart valves, N Engl J Med, 333, 11, 10.1056/NEJM199507063330103 Lupinetti, 1997, Comparison of human tissues and mechanical prostheses for aortic valve replacement in children, Circulation, 96, 321, 10.1161/01.CIR.96.1.321 Fann, 1996, Twenty-year clinical experience with porcine bioprosthesis, Ann Thorac Surg, 62, 1301, 10.1016/0003-4975(96)00629-7 Vongpatanasin, 1996, Prosthetic heart valves, N Engl J Med, 335, 407, 10.1056/NEJM199608083350607 Robbins, 1988, Cardiac valve replacement in children: a twenty year series, Ann Thorac Surg, 45, 56, 10.1016/S0003-4975(10)62398-3 Williams, 1982, Porcine heterograft valve replacement in children, J Thorac Cardiovasc, 85, 446, 10.1016/S0022-5223(19)39018-X Solymar, 1991, Prosthetic valves in children and adolescents, Am Heart J, 121, 557, 10.1016/0002-8703(91)90726-X Turrentine, 2001, Biological versus mechanical aortic valve replacement in children, Ann Thorac Surg, 71, S356, 10.1016/S0003-4975(01)02507-3 Jamieson, 1988, Carpentier–Edwards standard porcine bioprosthesis: primary tissue failure (structural valve degeneration) by age groups, Ann Thorac Surg, 46, 155, 10.1016/S0003-4975(10)65888-2 Chambers, 1997, Pulmonary autograft procedure for aortic valve disease; long-term results of the pioneer series, Circulation, 96, 2206, 10.1161/01.CIR.96.7.2206 Simon, 2001, Growth of the pulmonary autograft after the Ross operation in childhood, Eur J Cardiothorac Surg, 19, 118, 10.1016/S1010-7940(00)00638-2 Baskett, 1996, Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity?, J Thorac Cardiovasc Surg, 112, 1170, 10.1016/S0022-5223(96)70130-7 Stark, 1998, Fate of subpulmonary homograft conduits: determinants of late homograft failure, J Thorac Cardiovasc Surg, 115, 506, 10.1016/S0022-5223(98)70312-5 Tweddell, 2000, Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease, Circulation, 102, III130 Neuenschwandner, 2004, Heart valve Tissue Eng, Transpl Immunol, 12, 359, 10.1016/j.trim.2003.12.010 Schenke-Layland, 2003, Complete dynamic repopulation of decellularized heart valves by application of defined physical signals — an in vitro study, Cardiovasc Res, 60, 497, 10.1016/j.cardiores.2003.09.002 Hoerstrup, 2002, A new approach to completely autologous cardiovascular tissue in humans, ASAIO J, 48, 234, 10.1097/00002480-200205000-00006 Jockenhoevel, 2001, Fibrin gel — advantages of a new scaffold in cardiovascular Tissue Eng, Eur J Cardio-Thorac Surg, 19, 424, 10.1016/S1010-7940(01)00624-8 Grabenwöger, 1996, Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material, Ann Thorac Surg, 62, 772, 10.1016/S0003-4975(96)00442-0 Schoen, 1984, Bioprosthetic heart valve failure: pathology and pathogenesis, Cardiol Clin, 2, 717, 10.1016/S0733-8651(18)30720-3 Schoen, 1992, Heart valve anti-mineralization, Eur J Cardiothorac Surg, 6, S91, 10.1016/1010-7940(92)90030-2 O'Brien, 1999, The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation, Semin Thorac Cardiovasc Surg, 11, 194 Hilbert, 2004, Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep, J Heart Valve Dis, 13, 831 Steinhoff, 2000, Tissue Engineering of pulmonary heart valves on allogenic acellular matrix conduits, Circulation, 102, SIII50, 10.1161/01.CIR.102.suppl_3.III-50 Kasimir, 2003, Comparison of different decellularization procedures of porcine heart valves, Int J Artif Organs, 26, 421, 10.1177/039139880302600508 Rieder, 2004, Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells, J Thorac Cardiovasc Surg, 172, 399, 10.1016/j.jtcvs.2003.06.017 Kasimir, 2005, Presence and elimination of the Xenoantigen Gal (α1,3)Gal in tissue engineered heart valves, Tissue Eng, 11, 1274, 10.1089/ten.2005.11.1274 Sandrin, 1994, Gal alpha(1,3)Gal, the major xenoantigen (s) recognised in pigs by human natural antibodies, Immunol Rev, 141, 169, 10.1111/j.1600-065X.1994.tb00877.x Platt, 1991, Immunopathology of hyperacute xenograft rejection in a swine to primate model, Transplantation, 52, 214, 10.1097/00007890-199108000-00006 Stone, 1997, Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection, Transplantation, 63, 640, 10.1097/00007890-199703150-00005 Konakci, 2005, Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery, Eur J Clin Invest, 35, 17, 10.1111/j.1365-2362.2005.01441.x Murray, 1956, Homologous aortic valve segment transplants for aortic and mitral insufficiency, Angiology, 7, 466, 10.1177/000331975600700509 Heimbecker, 1968, The durability and fate of aortic valve grafts. An experimental study with a long term follow-up of clinical patients, J Cardiovasc Surg (Torino), 9, 511 Kerwin, 1962, Aortic valve homograft in the treatment for aortic and mitral insufficiency, N Engl J Med, 266, 852, 10.1056/NEJM196204262661702 Hogan, 1996, Human aortic valve allografts elicit a donor-specific immune response, J Thorac Cardiovasc Surg, 112, 1260, 10.1016/S0022-5223(96)70139-3 Hoekstra, 1998, Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies, Ann Thorac Surg, 66, 2022, 10.1016/S0003-4975(98)01058-3 Elkins, 2001, Humoral immune response to allograft valve tissue pretreated with an antigen reduction process, Semin Thorac Cardiovasc Surg, 13, 82 da Costa, 2005, Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation, Eur J Cardiothorac Surg, 27, 572, 10.1016/j.ejcts.2004.12.057 Bechtel, 2005, Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts, Eur J Cardiothorac Surg, 27, 410, 10.1016/j.ejcts.2004.12.017 Elkins, 2001, Recellularization of heart valve grafts by a process of adaptive remodeling, Semin Thorac Cardiovasc Surg, 13, 87 Simon, 2003, Early failure of the tissue engineered porcine heart valve Synergraft™ in paediatric patients, Eur J Cardio-Thorac Surg, 23, 1002, 10.1016/S1010-7940(03)00094-0 Kasimir, 2005, The decellularized porcine heart valve matrix in Tissue Eng: platelet adhesion and activation, Thromb Haemost, 94, 562, 10.1160/TH05-01-0025 Wagner, 2003, Platelet in inflammation and thrombosis, Arterioscler Thromb Vasc Biol, 23, 2131, 10.1161/01.ATV.0000095974.95122.EC Gorbet, 2003, Material-induced tissue factor expression but not CD11b upregulation depends on the presence of platelets, J Biomed Mater Res A, 67, 792, 10.1002/jbm.a.10155 Diacovo, 1996, Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18, Blood, 88, 146, 10.1182/blood.V88.1.146.146 Wilhelmi, 2003, Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep, Int J Artif Organs, 26, 411, 10.1177/039139880302600507 Caterina, 1991, Molecular insights into eukaryotic chemotaxis, FASEB J, 5, 3078, 10.1096/fasebj.5.15.1743439 Rieder, 2005, Tissue Engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells, Circulation, 111, 2792, 10.1161/CIRCULATIONAHA.104.473629 Coughlin, 2000, Thrombin signalling and protease-activated receptors, Nature, 407, 258, 10.1038/35025229 Osborn, 1990, Leukocyte adhesion to endothelium in inflammation, Cell, 62, 3, 10.1016/0092-8674(90)90230-C Mantovani, 1992, Cytokine regulation of endothelial cell function, FASEB, 6, 2591, 10.1096/fasebj.6.8.1592209